Concepedia

Publication | Open Access

Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer

DOIFull Paper Access

12

Citations

15

References

2023

Year

William A. Zammarrelli, Weining Ma, Kevin Espino, Sushmita Gordhandas, Effi Yeoshoua, Sarah Ehmann, Qin Zhou, Alexia Iasonos, Nadeem R. Abu‐Rustum, Carol Aghajanian,
Gynecologic Oncology

References

YearCitations

Page 1